FindTrial
Sign In

Effect of Second Stage Analgesia on Obstetric and Neonatal Outcomes

Effect of Second Stage Analgesia on Obstetric and Neonatal Outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005875
Enrollment
Unknown
Registered
2014-12-20
Start date
2014-12-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor pain

Interventions

analgesia group:labor analgesia during the second stage

Sponsors

Nanjing Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy nulliparous women, term (> or = 37 weeks), singleton

Exclusion criteria

Exclusion criteria: ASA 3 or 4, prior use of pain medicine, on magnesium, IV or PO analgesics used during labor, cervical dilation > or = 6cm

Design outcomes

Primary

MeasureTime frame
the length of the second stage;The pain VAS scores during second stage;The motor block as measure by Bromage scores;The maternal satisfaction score;Delivery models;Rates of operative delivery and episiotomy;Fetal weigh;Apgar score at 1 and 5 minutes;Fetal position at delivery;Umbilical blood gas analysis;—

Countries

China

Contacts

Public ContactXiaofeng Shen
sxf0418@126.com+86 13813832297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026